News/Medicine
Tempus AI acquires Ambry Genetics to advance precision medicine
Tempus AI's USD 600 million acquisition of Ambry Genetics combines artificial intelligence capabilities with genetic testing expertise to advance precision medicine. Deal Structure and Financing: The acquisition involves a mixed payment structure combining cash and stock components. The USD 600 million deal includes USD 375 million in cash and USD 225 million in shares USD 100 million of the share component is subject to a one-year lock-up period Ares Management Credit Funds provided the financing for the transaction Strategic Integration: The merger aims to enhance diagnostic capabilities and patient care through combined technologies. Ambry Genetics will maintain its operational independence...
read Feb 4, 2025New study finds that AI enhances patient-clinician communication
AI tools are emerging as a solution to help healthcare providers deliver personalized weight loss counseling at scale, addressing time constraints while maintaining quality patient communication. Core findings; A JAMA study presents evidence-based strategies for effective weight loss discussions between clinicians and patients, emphasizing personalized communication approaches. The research demonstrates that gentle conversation initiation and stigma-free discussions lead to better patient outcomes Customized messaging that considers patient history and experiences proves more effective than generic advice Structured support systems, including behavioral programs and medical treatments, show superior results compared to verbal guidance alone Current challenges: Healthcare providers face significant time...
read Jan 29, 2025Danish company Corti announces new AI models for healthcare
Medical AI company Corti has launched three specialized healthcare AI models to address critical issues of accuracy and reliability in medical settings, backed by nine years of peer-reviewed research. Key challenges driving innovation: Healthcare professionals are spending significant time correcting AI errors while expressing low confidence in current AI solutions. One-third of US healthcare professionals report spending up to three extra hours weekly fixing AI-generated mistakes Despite 74% of European healthcare professionals supporting AI use, 52% lack confidence in existing solutions The industry faces "pilot paralysis" where AI trials fail to progress due to accuracy, cost, and integration issues Core...
read Jan 27, 2025Stanford’s new multimodal AI model predicts cancer treatment outcomes
Stanford researchers have developed a new AI model called MUSK that combines clinical notes and pathology images to predict cancer treatment outcomes and personalize patient care. The innovation: MUSK (Multimodal transformer with Unified maSKed modeling) represents a significant advancement in medical AI by analyzing both clinical notes and pathology images without requiring manual data pairing. Unlike current AI models that rely on single data sources, MUSK mirrors how human pathologists make decisions by considering multiple types of medical information The model was pretrained on 50 million pathology images and 1 billion pathology-related text tokens covering 33 tumor types This large-scale...
read Jan 21, 2025Experts explain why AI models struggle to accurately diagnose cancer
AI's latest attempts to diagnose cancer through pathology and imaging analysis demonstrate both promise and significant challenges in achieving clinical-grade accuracy. Current landscape: The Mayo Clinic and Aignostics have developed Atlas, a new AI model trained on 1.2 million tissue samples, marking one of several recent efforts to apply artificial intelligence to cancer diagnosis. Atlas achieved 97.1% accuracy in identifying cancerous colorectal tissue, matching human pathologist diagnoses The model's performance varied significantly across different cancer types, with only 70.5% accuracy for prostate cancer biopsies Overall, Atlas matched human expert diagnoses 84.6% of the time across nine benchmarks Technical challenges: Processing...
read Jan 21, 2025A new AI tool may allow opticians to detect Alzheimer’s through routine eye exams
The development of an AI tool by Scottish researchers could enable high-street opticians to detect early signs of dementia through routine eye examinations. Project overview; The NeurEYE research team has compiled nearly one million eye scans from across Scotland to develop an AI algorithm that analyzes retinal blood vessels for signs of neurodegenerative diseases. The project combines expertise from researchers at the University of Edinburgh and Glasgow Caledonian University The database represents the largest collection of eye scans of its kind globally The technology could be integrated into routine eye examinations by 2026, with a prototype expected later this year...
read Jan 19, 2025How AI detects the hidden diseases doctors aren’t looking for
AI-powered opportunistic screening technology is enabling healthcare providers to detect undiagnosed diseases by analyzing routine CT scans and other medical imaging for conditions beyond their original purpose. The breakthrough case: Will Studholme's emergency room visit for food poisoning led to an unexpected osteoporosis diagnosis after AI technology analyzed his routine abdominal CT scan and identified a collapsed vertebra. The 58-year-old male patient would likely have gone undiagnosed without the AI screening, as he didn't fit the typical osteoporosis patient profile The early detection enabled doctors to begin preventative treatment with annual drug infusions to improve bone density How the technology...
read Jan 18, 2025Mayo Clinic and Mesmerise are using AI-powered digital humans to train healthcare professionals
Mayo Clinic and Mesmerise have partnered to create NeuRealities, a new venture that combines AI and immersive technologies to transform medical education and healthcare training. Key partnership details: Mayo Clinic's clinical expertise will be integrated with Mesmerise's AI and spatial computing capabilities to create advanced training solutions for healthcare professionals. The collaboration is founded on an exclusive worldwide agreement giving NeuRealities access to Mayo Clinic's extensive medical knowledge and expertise The platform combines AI-powered digital humans with adaptive learning environments to create personalized educational experiences Initial efforts are focused on developing CT training programs for radiologic technicians Technical innovations: NeuRealities...
read Jan 15, 2025Researchers use AI to create proteins that neutralize snake venom toxins
The University of Washington research team has successfully used AI to design novel proteins that can neutralize specific snake venom toxins, demonstrating a practical application of protein structure prediction technology. Research breakthrough; A team led by Nobel laureate David Baker developed artificial proteins capable of inhibiting specific toxins found in snake venom, particularly focusing on three-finger toxins common in mambas, taipans, and cobras. The research targeted two distinct types of three-finger toxins: those causing cellular toxicity and those blocking neurotransmitter receptors Current antivenoms require refrigeration and have limited shelf life, making treatment challenging in remote areas The AI-designed proteins could...
read Jan 12, 2025Novo Nordisk and Valo expand AI partnership to 20 drug programs targeting chronic diseases
Novo Nordisk and Valo Health have significantly expanded their AI-driven drug discovery partnership, increasing their program scope from 11 to 20 potential new treatments for obesity, diabetes, and cardiovascular disease. Partnership expansion details: The collaboration now represents a potential USD 4.6 billion opportunity for Valo Health through milestone payments, upfront fees, and royalties. Valo Health will receive an immediate upfront payment of USD 190 million plus equity investments The partnership scope has increased by 9 new programs, bringing the total to 20 drug development initiatives The focus remains on developing treatments for obesity, type 2 diabetes, and cardiovascular disease Technical...
read Jan 10, 2025Generative AI in life sciences could unlock $110B upside but faces scaling challenges
Generative AI adoption in life sciences shows high potential but faces significant scaling challenges, with only 5% of companies currently realizing competitive advantages despite widespread experimentation. Current state of adoption: The life sciences industry stands at a critical juncture in generative AI implementation, with potential annual value creation of $60-110 billion in pharmaceutical and medical products sectors. Industry-wide experimentation is universal, though only 32% of companies have initiated scaling efforts Over two-thirds of pharmaceutical and medical technology leaders plan significant increases in generative AI investments Just 5% of companies report achieving significant competitive advantages from their generative AI initiatives Primary...
read Jan 9, 2025Virgo’s AI model analyzes endoscopy videos using MetaAI’s DINOv2
MetaAI's DINOv2 computer vision technology is enabling Virgo, a San Diego-based medical company, to analyze endoscopy videos using artificial intelligence, with the goal of improving patient outcomes and advancing precision medicine. The innovation: Virgo has developed VirgoCloud, a system that captures and processes endoscopy videos, while also creating AutoIBD, an AI model that identifies potential candidates for inflammatory bowel disease clinical trials. The company has amassed over 1.75 million procedure videos, reportedly the largest dataset of its kind VirgoCloud connects to existing endoscopic equipment to capture, compress, and encrypt procedure videos The system transmits data to a HIPAA-compliant web portal...
read Jan 9, 202575 AI-discovered molecules are entering clinical trials
A new generation of artificial intelligence tools is accelerating drug discovery and development, with multiple AI-discovered molecules now entering clinical trials. The big picture: The pharmaceutical industry is witnessing a transformation as AI-driven drug discovery companies compete to develop new treatments for difficult diseases, potentially reducing the traditional 10-15 year, $2 billion development timeline. Insilico Medicine, a US-based startup, has developed an AI-discovered drug for idiopathic pulmonary fibrosis (IPF) that has shown promising results in early clinical trials At least 75 AI-discovered molecules have entered clinical trials, marking a significant milestone in pharmaceutical development Major tech companies like Alphabet have...
read Jan 9, 2025AI simulating human cells transforms predictive research without experiments
The development of AI-powered virtual cell simulations promises to transform biological research by enabling scientists to predict cellular behavior and responses without physical experiments. The big picture: Scientists are working to create computer programs that can simulate human cells, potentially revolutionizing drug development and disease research by predicting how cells respond to various stimuli. Scientists previously identified only hundreds of cell types, but new technologies have revealed thousands Traditional cellular research has been limited by the complexity of human cells, with approximately tens of trillions of cells forming intricate networks in the body Current experimental methods often involve significant guesswork, as...
read Jan 9, 2025AMD is investing in Absci to accelerate AI drug discovery
AMD and Absci Corporation have formed a strategic partnership worth $20 million to accelerate AI-driven drug discovery, with AMD providing advanced computing technology and making a significant investment in Absci. Key partnership details: AMD will integrate its Instinct accelerators and ROCm software into Absci's AI drug discovery platform to enhance the development of new therapeutic antibodies and biological drugs. The collaboration includes a $20 million private investment in public equity (PIPE) from AMD to Absci Absci will utilize AMD's high-performance computing solutions to power its de novo antibody design models The partnership aims to reduce infrastructure costs and accelerate innovation...
read Jan 9, 2025AI models easily absorb medical misinformation, study finds
Large language models (LLMs) can be easily compromised with medical misinformation by altering just 0.001% of their training data, according to new research from New York University. Key findings: Researchers discovered that injecting a tiny fraction of false medical information into LLM training data can significantly impact the accuracy of AI responses. Even when misinformation made up just 0.001% of training data, over 7% of the LLM's answers contained incorrect medical information The compromised models passed standard medical performance tests, making the poisoning difficult to detect For a large model like LLaMA 2, researchers estimated it would cost under $100...
read Jan 6, 2025How AI breakthroughs reshaped the healthcare landscape in 2024
A continued series of major advancements in healthcare technology occurred throughout 2024, primarily driven by artificial intelligence applications and new digital health solutions. Key technological shifts: The intersection of health and technology saw significant evolution in 2024, building upon pandemic-era innovations and expanding into new digital health territories. AI-powered medical scribes emerged as a transformative tool, saving physicians an average of one hour daily by automatically summarizing patient visits Healthcare executives ranked AI as the most promising emerging technology for the fourth consecutive year Digital health innovations expanded beyond traditional medical settings into everyday consumer products AI integration in healthcare:...
read Jan 3, 2025Defense Department completes pilot program testing AI chatbots in military medicine
The Department of Defense's Chief Digital and Artificial Intelligence Office (CDAO) has completed a pilot program testing AI chatbots in military medicine through crowdsourced security testing. Program Overview: The Crowdsourced AI Red-Teaming (CAIRT) Assurance Program evaluated Large Language Model (LLM) chatbots for military medical applications through collaborative testing with multiple stakeholders. Tech company Humane Intelligence led the initiative in partnership with the Defense Health Agency (DHA) and Program Executive Office, Defense Healthcare Management Systems Over 200 participants from various military medical institutions took part in the testing The program examined two specific use cases: clinical note summarization and a medical...
read Jan 1, 2025Dental AI Association launches to implement AI in clinical practice, education and research
Initial Overview: The Dental AI Association (DAIA) launched globally as the first organization dedicated to integrating artificial intelligence with dentistry, supported by the Global Summits Institute's World's Top Doctors initiative. Core Mission and Structure: DAIA aims to transform dental care worldwide by incorporating AI technology into clinical practice, education, and research. The organization will provide comprehensive AI certification programs through its Dental AI Academy Members will have access to advanced training programs and research opportunities A tiered membership structure has been implemented to accommodate diverse needs within the dental community Leadership Vision and Goals: The organization envisions AI integration across...
read Dec 29, 2024Swedish researchers use AI to pinpoint causes of cognitive decline
AI-powered research reveals key factors influencing brain aging through advanced analysis of brain scans and health data from hundreds of 70-year-old individuals. Study methodology and scope: Scientists at Karolinska Institutet employed artificial intelligence to analyze brain MRI scans from 739 Gothenburg residents, using a training dataset of over 18,800 images to establish baseline brain age predictions. The research team developed an AI model to calculate a "brain age gap" score, comparing predicted brain age against actual chronological age This innovative approach allowed researchers to identify specific factors that contribute to accelerated brain aging The study focused on 70-year-old participants to...
read Dec 29, 2024This new AI tool may eventually prevent devastating strokes
A new artificial intelligence tool is being tested in West Yorkshire to identify patients at risk of atrial fibrillation (AF) before symptoms appear by analyzing GP records. The innovation at hand; The AI algorithm, developed by researchers at the University of Leeds and Leeds Teaching Hospitals NHS Trust, searches through medical records for warning signs of potential AF development. The tool analyzes patient data including age, sex, ethnicity, and existing medical conditions like heart failure, high blood pressure, and diabetes The project, called Find-AF, is being funded by the British Heart Foundation and Leeds Hospitals Charity Initial trials are taking...
read Dec 20, 2024AI-powered blood testing shows promise in detecting early disease markers
The emerging field of AI-powered blood testing is showing promise in detecting diseases earlier and more accurately than traditional diagnostic methods. Recent breakthrough: Dr. Daniel Heller at Memorial Sloan Kettering Cancer Center has developed an innovative approach to detecting ovarian cancer using AI-enhanced nanotube technology. The technology utilizes specialized nanotubes that emit fluorescent light in response to molecular markers present in blood samples AI algorithms analyze complex patterns in the nanotube data that would be imperceptible to human observers Early results indicate higher accuracy rates compared to existing cancer biomarker tests, despite limited training data Industry developments: Multiple companies and...
read Dec 18, 2024Strategies to prevent the misuse of AI in biomedical applications
Increasing adoption of AI in scientific domains has created an urgent need for better frameworks to identify and prevent potential misuse, particularly in biomedical applications. Current landscape: The accelerating pace of AI development in scientific research has outstripped existing policies and safety guidelines, creating potential vulnerabilities. Recent breakthroughs in AI have demonstrated both promising benefits and concerning risks, including the possibility of generating harmful compounds or environmentally damaging substances The biomedical field faces particular challenges due to the dual-use nature of many AI applications Current regulatory frameworks are struggling to keep pace with technological advancement Proposed framework: A new perspective...
read Dec 17, 2024Dexcom integrates AI reports into its OTC glucose monitor
The integration of artificial intelligence into diabetes management takes a significant step forward as Dexcom enhances its over-the-counter continuous glucose monitoring system with AI-powered reporting capabilities. Key Innovation: Dexcom has upgraded its Stelo continuous glucose monitor (CGM) for Type 2 diabetes patients by implementing generative AI to create personalized weekly reports. The AI-generated reports provide customized recommendations related to diet, exercise, and sleep patterns This new feature replaces the previous template-based reporting system with more tailored insights The system aims to help users better understand how their lifestyle choices affect their glucose levels Regulatory Compliance: Dexcom has developed this AI...
read